Clinical Utility of the HELT-E<sub>2</sub>S<sub>2</sub> Score for Risk Stratification in Patients with Acute Decompensated Heart Failure: Insights from the CURE-HF Registry.

Intern Med · 2025 · PMC12702539 · PMID 40335300

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

Meanwhile, the JROADHF study (registered in 2013), KCHF study (registered in 2014-2016), and REALITY-AHF study (registered in 2014-2015) reported a mean age of 78 years ( 3 , 17 , 18 ), indicating a clear trend of increasing age among hospitalized patients with ADHF in recent years.

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Clinical Utility of the HELT-E&lt;sub&gt;2&lt;/sub&gt;S&lt;sub&gt;2&lt;/sub&gt; Score for Risk Stratification in Patients with Acute Decompensated Heart Failure: Insights from the CURE-HF Registry.

The sentences

Clinical Utility of the HELT-E<sub>2</sub>S<sub>2</sub> Score for Risk Stratification in Patients with Acute Decompensated Heart Failure: Insights from the CURE-HF Registry.